Temasek backs $55m Series A for US-based RNA gene therapy startup Locana

Temasek backs $55m Series A for US-based RNA gene therapy startup Locana

Mars W. Mosqueda Jr.

23 May, 2019

ARCH Venture Partners Locana Temasek

Printed by Unregistered user on Thu, 31 Jul 2025 13:30:21 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek unit to raise $598m via private equity bonds

Singapore's $200b state investor Temasek seeks to expand US holdings

Read more from World

Dutch pension fund APG commits $646m to Octopus Australia

Earnings and Results

Keppel’s H1 profit rises on strong infrastructure, real estate operations